Efficacy & Safety of Anlotinib in Adjuvant Therapy for High-grade Soft

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04577014` - Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma	Phase 1/Phase 2
Recruiting	`NCT04656262` - Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients	Phase 3
Recruiting	`NCT03077178` - Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over	N/A
Not yet recruiting	`NCT06110650` - A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma	N/A
Terminated	`NCT03735758` - Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib	Phase 4
Enrolling by invitation	`NCT03134742` - Radiation Effects on Bone
Not yet recruiting	`NCT06252727` - Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)	Phase 1
Recruiting	`NCT04617327` - Pre-operative RadiothErapy for Soft Tissue SarcOmas	N/A
Recruiting	`NCT06385288` - Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas	N/A
Recruiting	`NCT05116254` - Sarcomas and DDR-Inhibition; a Combined Modality Study	Phase 1
Active, not recruiting	`NCT03526679` - Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma	Phase 1/Phase 2
Recruiting	`NCT04008238` - Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients	N/A
Recruiting	`NCT04095208` - Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study	Phase 2
Recruiting	`NCT04330456` - Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy	N/A
Completed	`NCT03833037` - Study of a Cohort of Cases of Synovial Sarcoma Treated in the Orthopedic Surgery and Traumatology Department of the Hospital de Sant Pau Between 1983 and 2016
Completed	`NCT03056599` - Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma	Phase 1
Recruiting	`NCT05961761` - Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients	Phase 2
Recruiting	`NCT06273852` - A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors	Early Phase 1
Recruiting	`NCT05182164` - Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas	Phase 2
Withdrawn	`NCT03104335` - Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial	Phase 2

NCT number	NCT03951571
Study type	Interventional
Source	Fudan University
Contact	Wangjun Yan, M.D.
Phone	+86 18121299399
Email	yanwj@fudan.edu.cn
Status	Not yet recruiting
Phase	Phase 2
Start date	May 13, 2019
Completion date	August 13, 2022

Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms